Aurobindo Pharma
Aurobindo Pharma to commercialise China plant in third quarter of FY25: CFO
Aurobindo Pharma arm gets warning letter from USFDA for formulations unit in Telangana
Aurobindo Pharma commissions four plants in Andhra Pradesh including Pen-G facility
Aurobindo Pharma shares tumble nearly 7 pc in early trade; hit 52-week low after Q2 earnings
Aurobindo Pharma arm gets final USFDA nod for Vasopressin injection
/newsdrum-in/media/agency_attachments/2025/01/29/2025-01-29t072616888z-nd_logo_white-200-niraj-sharma.jpg)
/newsdrum-in/media/media_files/MxiOumI8DazzlGgzLykO.jpg)
/newsdrum-in/media/media_files/cQppuFUNHk0W26NnixMY.jpg)
/newsdrum-in/media/post_banners/5xtyAQwxBskkkNuyklkI.jpg)
/newsdrum-in/media/media_files/5KUALZRQ4i4nWIYxRVEj.jpg)
